Overview of Cervical Cancer Screening Practices in the Extended Middle East and North Africa Countries

Highlights ► Organized cervical cancer screening is lacking in most of countries of the EMENA. ► The majority of cervical cancers are diagnosed late, leading to high mortality. ► Women face many political, cultural, and financial barriers to gaining access to screening. ► Management of abnormal scre...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2013-12, Vol.31, p.G51-G57
Main Authors: Sancho-Garnier, Hélène, Khazraji, Youssef Chami, Cherif, Moktar Hamdi, Mahnane, Abbes, Hsairi, Mohamed, Shalakamy, Amr El, Osgul, Nejat, Tuncer, Murat, Jumaan, Aisha O, Seoud, Muhieddine
Format: Article
Language:English
Subjects:
acetic acid
Africa, Northern - epidemiology
algorithms
Allergy and Immunology
cell biology
cervical cancer screening
Early Detection of Cancer - economics
Early Detection of Cancer - methods
Extended Middle East
Female
guidelines
Gulf countries
Health Policy
Health Services Administration - economics
HPV
Humans
Middle East
Middle East - epidemiology
mortality
North Africa
Papillomavirus Infections - complications
Papillomavirus Infections - epidemiology
politics
public health
quality control
screening
social barriers
uterine cervical neoplasms
Uterine Cervical Neoplasms - epidemiology
Uterine Cervical Neoplasms - etiology
vaccines
women
Yemen
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights ► Organized cervical cancer screening is lacking in most of countries of the EMENA. ► The majority of cervical cancers are diagnosed late, leading to high mortality. ► Women face many political, cultural, and financial barriers to gaining access to screening. ► Management of abnormal screening results is neither widely available nor standardized. ► Even with mass vaccination, organized screening programs will still be necessary.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2012.06.046